Login
Toggle sidebar

Lint: endometrial-carcinoma-staging-2

endometrial-carcinoma-staging-2
Citation Preceding Space
error

"An updated FIGO system was introduced in 202310. The new system includes non-anatomical parameters such as tumour histological type, grade, lymphovascular invasion (LVSI) and molecular subtype."

Line 6:49 · Citations must have a preceding space, e.g. needs evidence <sup>2</sup>. '<sup>10</sup>'
Strong List Colon Position
error

"stage I: limited to the uterine corpus and ovary"

Line 10:4 · When enboldening an intro, the colon should not be bold. '<strong>stage I: </strong>limited'

"Ia: limited to the endometrium or non-aggressive histological type with no or less than half (≤ 50%) myometrial invasion, no or focal LVSI"

Line 12:8 · When enboldening an intro, the colon should not be bold. '<strong>Ia:</strong> limited'

"Ib: non-aggressive histological type with invasion equal to or more than half (≥ 50%) of the myometrium, no or focal LVSI"

Line 13:8 · When enboldening an intro, the colon should not be bold. '<strong>Ib: </strong>non'

"Ic: aggressive histological type confined to the endometrium or to a polyp"

Line 14:8 · When enboldening an intro, the colon should not be bold. '<strong>Ic: </strong>aggressive'

"stage II: cervical stromal involvement without extrauterine spread or with extensive LVSI or aggressive histological type with myometrial invasion"

Line 18:4 · When enboldening an intro, the colon should not be bold. '<strong>stage II:</strong> cervical'

"IIa: cervical stromal involvement and non-aggressive histological type"

Line 20:8 · When enboldening an intro, the colon should not be bold. '<strong>IIa:</strong> cervical'

"IIb: extensive LVSI and non-aggressive histological type"

Line 21:8 · When enboldening an intro, the colon should not be bold. '<strong>IIb: </strong>extensive'

"IIc: aggressive histological type with myometrial invasion of any depth"

Line 22:8 · When enboldening an intro, the colon should not be bold. '<strong>IIc: </strong>aggressive'

"stage III: local or regional spread of the tumour"

Line 26:4 · When enboldening an intro, the colon should not be bold. '<strong>stage III:</strong> local'

"IIIa: tumour invades the serosa of the body of the uterus and/or adnexa"

Line 28:8 · When enboldening an intro, the colon should not be bold. '<strong>IIIa: </strong>tumour'

"IIIb: vaginal or parametrial involvement"

Line 29:8 · When enboldening an intro, the colon should not be bold. '<strong>IIIb: </strong>vaginal'

"IIIc: pelvic or para-aortic lymphadenopathy"

Line 30:8 · When enboldening an intro, the colon should not be bold. '<strong>IIIc: </strong> pelvic'

"stage IV: involvement of intestinal/bowel and/or bladder mucosa and/or distant metastasis"

Line 34:4 · When enboldening an intro, the colon should not be bold. '<strong>stage IV: </strong>involvement'

"IVa: bladder or intestinal/bowel mucosal involvement"

Line 36:8 · When enboldening an intro, the colon should not be bold. '<strong>IVa:</strong> bladder'

"IVb: extrapelvic peritoneal involvement"

Line 37:8 · When enboldening an intro, the colon should not be bold. '<strong>IVb: </strong>extrapelvic'

"IVc: distant metastases"

Line 38:8 · When enboldening an intro, the colon should not be bold. '<strong>IVc: </strong>distant'
Acronyms
warning

"Staging can be based on the TNM or FIGO system."

Line 3:35 · 'TNM' has no definition. Spell it out if it's unfamiliar to the audience.

"Staging can be based on the TNM or FIGO system."

Line 3:49 · 'FIGO' has no definition. Spell it out if it's unfamiliar to the audience.

"FIGO system"

Line 5:5 · 'FIGO' has no definition. Spell it out if it's unfamiliar to the audience.

"An updated FIGO system was introduced in 202310. The new system includes non-anatomical parameters such as tumour histological type, grade, lymphovascular invasion (LVSI) and molecular subtype."

Line 6:15 · 'FIGO' has no definition. Spell it out if it's unfamiliar to the audience.

"Revised 2023 FIGO staging for carcinoma of the endometrium 10:"

Line 7:17 · 'FIGO' has no definition. Spell it out if it's unfamiliar to the audience.

"The histological type and grade, LVSI must be included in all cases. Molecular subtype of tumour (POLEmut, MMRd, NSMP, p53abn) is encouraged in all patients if available. The molecular subtype modifies the I and II stages. POLEmut endometrial carcinoma, limited to the corpus of uteri or with cervical involvement regardless of the degree of LVSI is now classified as Stage IAmPOLEmut, whereas a p53abn endometrial carcinoma limited to the corpus of uteri with or without cervical involvement regardless of the degree of myometrial invasion and LVSI is classified as Stage IICmp53abn. Findings of MMRd or NSMP subtypes do not modify FIGO 2023 system stage."

Line 40:126 · 'NSMP' has no definition. Spell it out if it's unfamiliar to the audience.

"The histological type and grade, LVSI must be included in all cases. Molecular subtype of tumour (POLEmut, MMRd, NSMP, p53abn) is encouraged in all patients if available. The molecular subtype modifies the I and II stages. POLEmut endometrial carcinoma, limited to the corpus of uteri or with cervical involvement regardless of the degree of LVSI is now classified as Stage IAmPOLEmut, whereas a p53abn endometrial carcinoma limited to the corpus of uteri with or without cervical involvement regardless of the degree of myometrial invasion and LVSI is classified as Stage IICmp53abn. Findings of MMRd or NSMP subtypes do not modify FIGO 2023 system stage."

Line 40:649 · 'NSMP' has no definition. Spell it out if it's unfamiliar to the audience.

"The histological type and grade, LVSI must be included in all cases. Molecular subtype of tumour (POLEmut, MMRd, NSMP, p53abn) is encouraged in all patients if available. The molecular subtype modifies the I and II stages. POLEmut endometrial carcinoma, limited to the corpus of uteri or with cervical involvement regardless of the degree of LVSI is now classified as Stage IAmPOLEmut, whereas a p53abn endometrial carcinoma limited to the corpus of uteri with or without cervical involvement regardless of the degree of myometrial invasion and LVSI is classified as Stage IICmp53abn. Findings of MMRd or NSMP subtypes do not modify FIGO 2023 system stage."

Line 40:677 · 'FIGO' has no definition. Spell it out if it's unfamiliar to the audience.

"FIGO staging system"

Line 51:11 · 'FIGO' has no definition. Spell it out if it's unfamiliar to the audience.
Emphasis
warning

"The histological type and grade, LVSI must be included in all cases. Molecular subtype of tumour (POLEmut, MMRd, NSMP, p53abn) is encouraged in all patients if available. The molecular subtype modifies the I and II stages. POLEmut endometrial carcinoma, limited to the corpus of uteri or with cervical involvement regardless of the degree of LVSI is now classified as Stage IAmPOLEmut, whereas a p53abn endometrial carcinoma limited to the corpus of uteri with or without cervical involvement regardless of the degree of myometrial invasion and LVSI is classified as Stage IICmp53abn. Findings of MMRd or NSMP subtypes do not modify FIGO 2023 system stage."

Line 40:102 · Italics should be used only in exceptional circumstances: '<em>POLEmut</em>, MMRd, NSMP, p53abn) is encouraged in all patients if available. The molecular subtype modifies the I and II stages. <em>POLEmut</em>'
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Staging"

Line 2:1 · "Staging" is not a recognised heading for this article type.

"FIGO system"

Line 5:1 · "FIGO system" is not a recognised heading for this article type.
Oxford Comma
suggestion

"Ia: limited to the endometrium or non-aggressive histological type with no or less than half (≤ 50%) myometrial invasion, no or focal LVSI"

Line 12:137 · Use the Oxford comma in 'invasion, no or focal'.

"Ib: non-aggressive histological type with invasion equal to or more than half (≥ 50%) of the myometrium, no or focal LVSI"

Line 13:118 · Use the Oxford comma in 'myometrium, no or focal'.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0